{
    "nct_id": "NCT05334004",
    "official_title": "A Phase I Study of Intra-anally Administered Lopinavir/Ritonavir in People Living With HIV (PLWH) With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)",
    "inclusion_criteria": "* willing to provide informed consent\n* greater than or equal to 18 years of age\n* Diagnosis of biopsy-confirmed HGAIN\n* Human immunodeficiency virus (HIV)-positive with CD4 count greater than 200 cells/mm^3 at screening and virologically suppressed on HIV-1 antiretroviral therapy (ART) within last 12 months\n* willing to comply with all study procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnosis of low-grade anal dysplasia (AIN, low-grade squamous intraepithelial lesion (LSIL)) by HRA.\n* CD4 count less than 200 cells/mm^3 at the time of consideration for entry into the study\n* unable to provide informed consent\n* Pregnant or breastfeeding female\n* Currently receiving systemic chemotherapy or radiation therapy for another cancer.\n* Have received topical therapy for anal dysplasia previously",
    "miscellaneous_criteria": ""
}